Benign prostate Hyperplasia. Enlarged prostate
Conditions
Interventions
Intervention 1: Intervention group: Ampol of 1 vial of Transamin 500 mg (Caspian Company Rasht Drug) will be injected into the serum during an operation in the Tranexamic Acid group. Intervention 2: I
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
Male
Age
60 Years to 90 Years
Inclusion criteria
Inclusion criteria: Male gender 60 to 90 year-old Satisfaction for performing TURP surgery
Exclusion criteria
Exclusion criteria: Coagulation disorders (hemophilia and ...) Liver Disease (Cirrhosis and ...) Uses of anticoagulant medication (Warfarin and Heparin and Plavix) History of heart disease History of thrombotic stroke
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding status after TURP surgery. Timepoint: Within 48 hours after surgery. Method of measurement: Volume of fluid in the urethra for hematuria, the amount of hemoglobin before and after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| The amount of bleeding during and after the TURP operation. Timepoint: During and after the TURP operation. Method of measurement: Hemoglobin level and serum volume of used washing. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactYousef Kolookhi
Islamic Azad University
Outcome results
None listed